Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Alector Inc (ALEC)

Alector Inc (ALEC)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 2,370,199
  • Shares Outstanding, K 79,033
  • Annual Sales, $ 21,220 K
  • Annual Income, $ -105,390 K
  • 60-Month Beta 1.02
  • Price/Sales 112.89
  • Price/Cash Flow N/A
  • Price/Book 6.11

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 7 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/20
See More
  • Average Estimate -0.51
  • Number of Estimates 4
  • High Estimate -0.45
  • Low Estimate -0.56
  • Prior Year -0.36
  • Growth Rate Est. (year over year) -41.67%

Price Performance

See More
Period Period Low Period High Performance
1-Month
25.53 +17.47%
on 05/15/20
34.89 -14.04%
on 05/26/20
+1.91 (+6.80%)
since 05/05/20
3-Month
20.65 +45.23%
on 03/16/20
34.89 -14.04%
on 05/26/20
+0.54 (+1.83%)
since 03/05/20
52-Week
13.64 +119.87%
on 08/15/19
35.93 -16.53%
on 02/07/20
+13.18 (+78.41%)
since 06/05/19

Most Recent Stories

More News
Alector (ALEC) Reports Q1 Loss, Lags Revenue Estimates

Alector (ALEC) delivered earnings and revenue surprises of -10.42% and -32.35%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?

ALEC : 29.99 (-1.06%)
Alector: 1Q Earnings Snapshot

SOUTH SAN FRANCISCO, Calif. (AP) _ Alector Inc. (ALEC) on Wednesday reported a loss of $40 million in its first quarter.

ALEC : 29.99 (-1.06%)
Fate Therapeutics (FATE) Looks Good: Stock Adds 8.9% in Session

Fate Therapeutics (FATE) saw a big move last session, as its shares jumped nearly 9% on the day, amid huge volumes.

FATE : 28.21 (-6.09%)
ALEC : 29.99 (-1.06%)
Is Alector (ALEC) Outperforming Other Medical Stocks This Year?

Is (ALEC) Outperforming Other Medical Stocks This Year?

ALEC : 29.99 (-1.06%)
Alector (ALEC) Reports Q4 Loss, Misses Revenue Estimates

Alector (ALEC) delivered earnings and revenue surprises of -2.27% and -37.49%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock?

ALEC : 29.99 (-1.06%)
Alector: 4Q Earnings Snapshot

SOUTH SAN FRANCISCO, Calif. (AP) _ Alector Inc. (ALEC) on Tuesday reported a loss of $30.5 million in its fourth quarter.

ALEC : 29.99 (-1.06%)
Alector (ALEC) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

Alector (ALEC) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

ALEC : 29.99 (-1.06%)
What Makes Alector (ALEC) a New Buy Stock

Alector (ALEC) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

ALEC : 29.99 (-1.06%)
Is Alector (ALEC) Outperforming Other Medical Stocks This Year?

Is (ALEC) Outperforming Other Medical Stocks This Year?

ALEC : 29.99 (-1.06%)
Are Options Traders Betting on a Big Move in Alector (ALEC) Stock?

Investors need to pay close attention to Alector (ALEC) stock based on the movements in the options market lately.

ALEC : 29.99 (-1.06%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Buy with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Trade ALEC with:

Business Summary

Alector Inc. is a clinical stage biotechnology company pioneering immuno-neurology, a novel therapeutic approach for the treatment of neurodegenerative diseases. Its product portfolio includes AL001, AL101, Al002 and AL003 which are in clinical stage. Alector Inc. is headquartered in South San Francisco,...

See More

Key Turning Points

2nd Resistance Point 31.27
1st Resistance Point 30.63
Last Price 29.99
1st Support Level 29.62
2nd Support Level 29.25

See More

52-Week High 35.93
Last Price 29.99
Fibonacci 61.8% 27.42
Fibonacci 50% 24.78
Fibonacci 38.2% 22.15
52-Week Low 13.64

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar